Corner Therapeutics
PrivateLast Round
Series A
Apr 18, 2024
Total Funding Raised
$54M
Company Overview
Corner Therapeutics is a biotechnology company specializing in research services that enhance memory T cell activation for long-lasting immunity.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corner Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Corner Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 18, 2024 |
Key People
Founding team and executive leadership
Corner Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cockrell Interests | Series A |
| The Bill & Melinda Gates Foundation Trust | Series A |
| Ziff Capital Partners | Series A |
| Tanis Ventures | Series A |
Corner Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Corner Therapeutics's valuation, stock price, and market status.
